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Abstract Peroxisomes perform a range of diﬀerent functions,
dependent upon organism, tissue type, developmental stage or
environmental conditions, many of which are connected with lipid
metabolism. This review summarises recent research on ATP
binding cassette (ABC) transporters of the peroxisomal mem-
brane (ABC subfamily D) and their roles in plants, fungi and ani-
mals. Analysis of mutants has revealed that peroxisomal ABC
transporters play key roles in speciﬁc metabolic and developmen-
tal functions in diﬀerent organisms. A common function is import
of substrates for b-oxidation but much remains to be determined
concerning transport substrates and mechanisms which appear to
diﬀer signiﬁcantly between phyla.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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1. Introduction: peroxisome functions and the requirement for
import of substrates
Peroxisomes are (virtually) ubiquitous organelles of eukary-
otic cells which exhibit marked morphological and metabolic
plasticity, depending on organism, cell type and prevailing
environmental conditions. They perform a range of functions
in diﬀerent taxa, some of which are organism speciﬁc and some
of which are common to all eukaryotes (Table 1; [1]). Although
this diversity of function is reﬂected in the plasticity of peroxi-
somes, b-oxidation of fatty acids and the generation and deg-
radation of hydrogen peroxide are the distinctive general
biochemical characteristics of this organelle [2,3].
The peroxisome is bounded by a single membrane of similar
composition to the endoplasmic reticulum. In order to carry
out its various metabolic and developmental functions, the per-
oxisomal membrane must regulate import and export of metab-
olites and proteins and plays an important role in co-ordination
of peroxisomal metabolism with that of other compartments, in
particular, the mitochondrion and also plastids in photosyn-
thetic organisms. Although major advances have been made
in understanding the protein import apparatus of peroxisomes
[4], the roles of integral and membrane-associated proteins in
transport of solutes are relatively poorly characterised, except
in yeast where molecular genetic approaches have led to consid-
erable advances in understanding peroxisomal function [5,6].
This review focuses on the roles of ATP binding cassette
(ABC) superfamily transporters in peroxisome biology.
2. Properties of the peroxisomal membrane
The classical concept of a biological membrane is of a lipid
barrier that is selectively permeable to solutes and macromole-
cules owing to the presence of speciﬁc proteins which mediate
transport of these entities. Whilst hydrophobic and apolar mol-
ecules can cross the lipid bilayer by diﬀusion, polar, hydrophilic
solutes and large molecules require speciﬁc proteinaceous trans-
port systems. In the case of the peroxisome, a number of authors
have suggested that the peroxisomal membrane is essentially
porous to a range of small molecules [7–10]. This view is sup-
ported by studies with osmotically shocked peroxisomes in
whichmembranes were damaged yet thematrix retained its met-
abolic integrity. This was ascribed to arrangement of matrix en-
zymes into an aggregated core of multienzyme complexes which
functions as a metabolon [8,10–12]. Several studies have de-
scribed relatively non-speciﬁc porins, thought to be responsible
for transfer of metabolites across the peroxisomal membrane
[10,12–14]. However, the latter scenario is inconsistent with
more recent ﬁndings: although there are conﬂicting reports con-
cerning peroxisomal pH values, several groups have demon-
strated the existence of a pH gradient between the cytosol and
peroxisomal matrix, suggesting that transport of protons be-
tween these compartments is controlled [15–17]. Whilst the
membranes of isolated peroxisomes appear tobe porous to small
substrates, the transport of bulky cofactors such as NAD(P)H
and CoA is indeed restricted [18] and genetic manipulation of
a number of peroxisomal transport systems has conﬁrmed the
view that import and export of a range of ions, cofactors, metab-
olites and proteins is tightly controlled and protein-mediated
in vivo as is the case for other organelles [15–17,19–22].
3. b-Oxidation and fatty acid transport
b-Oxidation is the major process for the degradation of fatty
acids and also the phylum-speciﬁc biosynthesis of important
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Table 1
Metabolic functions associated with peroxisomes
Metabolic pathway Function Species distribution Consequence of mutation References
Core b-oxidation of fatty
acids
Energy production;
membrane lipid turnover;
membrane breakdown in
senescence
Essentially all Inability to grow on fatty acids as
sole carbon source (fungi);
reduced pathogenicity (fungi).
Defects in germination, seedling
establishment or reproductive
development depending on the
speciﬁc defect (plants)
[23,24,131,132]
Neurological abnormalities,
developmental delay, hypotonia,
cranio-facial abnormalities and
seizure depending upon the
speciﬁc defect (mammals)
b-Oxidation of aromatic and
cyclic compounds
Production of signal
molecules from precursors.
For example, production of
JA requires speciﬁc
peroxisomal acyl CoA
synthetases and OPR3 plus
core b-oxidation pathway.
Synthesis of IAA from IBA
and possibly salicylic acid
from trans-cinnamic acid,
likely requires specialised
activating enzymes and
thioesterases
Arabidopsis, tomato,
probably all plants
Complete block in JA
biosynthesis results in sterility
due to failure of pollen
production and compromised
defence responses
[115,133–137]
Mutants in conversion of IBA to
IAA compromise b-oxidation,
peroxisome biogenesis and also
responses to endogenous IBA
aﬀecting root elongation and
lateral root initiation
Prostaglandins and
leukotrienes are also (partly)
degraded by b-oxidation in
peroxisomes in mammalian
cells
Mammals [138,139]
a-Oxidation of fatty acids Breakdown of phytanic acid
and other b-methyl fatty
acids (mammals). Possible
(unproven) role in
chlorophyll breakdown
(plants). Possible role in
response to pathogens
(plants)
Mammals, plants Defects in phytanoyl CoA
hydroxylase in humans results in
Refsum disease
[24,131,140]
Branched chain fatty acid
oxidation
Breakdown of branched
chain fatty acids such as
pristanoyl-CoA, di and
trihydroxycholestanoyl CoA
(derived from cholesterol)
leading to the production of
bile salts
Mammals 2-Methylacyl-CoA racemase
deﬁciency results in adult onset
sensory motor neuropathy
[131,141]
Branched chain amino acid
catabolism
Breakdown of valine. b-
Hydroxyisobutyryl CoA
hydrolase is peroxisomal in
Arabidopsis. A number of
related proteins with putative
peroxisome targeting signals
are present in the
Arabidopsis genome.
Breakdown of leucine:
HMG-CoA lyase may be
targeted to both peroxisomes
and mitochondria in
Arabidopsis and mammals
Plants, mammals? Accumulation of toxic
methylacrylyl-CoA inhibits
b-ketoacyl thiolase and blocks
b-oxidation, leading to a
b-oxidation deﬁciency
[137,142–144]
Glyoxylate cycle Conversion of fat to
carbohydrate
(gluconeogenesis)
Plants, fungi, including
Leptosphaeria maculans,
and some yeasts
Compromised seedling
establishment under sub-optimal
conditions (Arabidopsis icl
mutant); reduced pathogenicity
(Leptosphaeria maculans;
Candida albicans icl mutants)
[145–148]
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Table 1 (continued)
Metabolic pathway Function Species distribution Consequence of mutation References
Mammals lack the glyoxylate cycle
but glyoxylate can be converted to
glycine in the liver by alanine
glyoxylate transferase (AGT)
which is peroxisomal in humans
and many other vertebrates
Patients with defective AGT
convert glyoxylate to oxalate
resulting in the disorder primary
hyperoxaluria type I
Plasmalogen
biosynthesis
Synthesis of ether-linked
phospholipids (plasmalogens)
which are particularly important
in membranes of neural cells.
Dihydroxyacetone phosphate
acyl transferase (DHAPAT) or
alkyldihydroxyacetonephosphate
synthase (ADHAPS) which
catalyse the ﬁrst 2 steps of the
pathway, are peroxisomal in
humans and trypanosomes
Mammals,
trypanosomes
All patients with mutations in
DHAPAT or ADHAPS show
signs and symptoms of
rhizomelic chondrodysplasia
punctata which include short
stature, facial abnormalities,
spasticity, severe mental
retardation and abnormal bone
ossiﬁcation
[131,149,150]
Isoprenoid biosynthesis Synthesis of sterols such as
cholesterol and quinones such as
ubiquinone. HMG-CoA
reductase is peroxisomal in
trypanosomes. Conﬂicting data
concerning the peroxisomal
location of isoprenoid synthesis
in mammals
Mammals,
trypanosomes
[149,151,152]
Glycolysis Compartmentalisation of
glycolysis within specialised
peroxisomes called glycosomes
allows glycolysis to continue
anaerobically whist maintaining
the redox balance as well as
compensating for the lack of
regulation of trypanosome
hexokinase and
phosphofructokinase
Trypanosomes Loss of compartmentation of
glycolytic enzymes is highly
detrimental. Blood stream form
trypanosomes die when
peroxisome biogenesis is
inhibited or cytosolic
phosphoglycerate kinase is
expressed
[149,153]
Pentose phosphate
pathway
Recycling ofNADP+ via glucose –
phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase
Plants, trypanosomes [149]
Photorespiration Recycling of phosphoglycolate
produced by oxygenase activity
of Ribulose bisphosphate
carboxylase oxygenase
Plants Mutant plants are sensitive to
atmospheric levels of oxygen and
require elevated CO2
[154]
Production of
glycine-betaine
Betaine aldehyde dehydrogenase
(BADH) catalyses the last step of
the biosynthesis of the
compatible osmolyte glycine-
betaine and is peroxisomal in rice
and barley
Some plant species Overproduction of barley BADH
in rice increases salt, heat and
cold tolerance
[155,156]
Lysine biosynthesis Biosynthesis of lysine from acetyl
CoA and 2-oxoglutarate. LYS4
and LYS1 catalysing the 4th and
11th steps of the pathway have
beendetermined experimentally to
be in peroxisomes. LYS9, LYS12
and LYS2 have a putative PTS
Saccharomyces cerevisiae Mutants in the pathway are all
lysine auxotrophs. Some mutants
are also impaired in growth on
lysine deﬁcient media
[157,158]
Penicillin biosynthesis Acyl-CoA:6-aminopenicillanic
acid acetyl transferase which
catalyses the ﬁnal step in penicillin
biosynthesis by replacing the a-
adipyl side chain with
phenylacetate to give penicillin G
is peroxisomal. Phenylactetate
CoA ligase (PCL) also has a PTS1
Penicillium chrysogenum;
Aspergillus nidulans
Aspergillus nidulans mutant
defective in peroxisome
biogenesis still made penicillin
but mistargeting of the acyl
transferase abolished penicillin
biosynthesis suggesting may need
2 or more enzymes (AT and
PCL?) in same compartment
[159,160]
(continued on next page)
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lipid-derived molecules such as plasmalogens, bile acids and
jasmonates in eukaryotes (Table 1). Most of the genes involved
have been identiﬁed in animals, yeast and plants [23–25]. In
yeast and plants, b-oxidation of straight chain fatty acids is
conﬁned to the peroxisome, whereas in mammals, initial chain
shortening of very long-chain fatty acids (VLCFA; C P 22:0)
occurs in the peroxisome and b-oxidation is completed in the
mitochondrion [23,24,26,27]. Transport of substrates for b-oxi-
dation across the peroxisomal membrane is a key step in this
pathway. Prior to b-oxidation, fatty acids are activated by thi-
oesteriﬁcation to Coenzyme A (CoA), a process which occurs
in the cytosol, on the ER or in the peroxisome, dependent on
chain length and organism. This determines the nature of the
molecular species that must cross the peroxisomal membrane
and has implications for the mechanism of transport. Fatty
acyl CoAs are amphipathic in nature and therefore require a
transport protein to cross lipid bilayers. In contrast, physico-
chemical properties predict that many fatty acids should be
membrane permeable and do not require a transporter
[28,29]. However, it has been shown that other membrane-per-
meable molecules such as ammonium and water have speciﬁc
membrane-bound transporters and that this permits higher
rates of transport, selectivity and co-ordination with other cel-
lular processes. Moreover, there is evidence that fatty acid
transport is a saturable, protein-dependent process [30]. Both
passive and membrane-protein-mediated transport of free fatty
acids can be coupled with activation on one side of the mem-
brane, a process known as vectorial acylation. Thus transport
Table 1 (continued)
Metabolic pathway Function Species distribution Consequence of mutation References
Degradation of purines/
synthesis of ureides
Xanthine is converted to urate by
xanthine dehydrogenase which is
peroxisomal in some species.
Urate oxidase (uricase) and
allantoinase are found in
peroxisomes from many species.
Allantoic acid can be further
metabolised to glyoxylate and
urea in many fungi. The ureides
allantoin and allantoic acid are
the major form of ﬁxed nitrogen
transported by tropical legumes
Mammals, plants
amphibia, fungi (yeasts
but not Saccharomyces
cerevisiae)
Antisense down regulation of
uricase resulted in peroxisomes of
reduced size and nitrogen
deﬁciency
[161–163]
Catabolism of
polyamines
Polyamine oxidases have been
identiﬁed in plants and mammals
that carry putative peroxisome
targeting signals
Plants, mammals [137,164]
Degradation of D-amino
acids
D-Amino acids can utilised by
many fungi as a carbon and
nitrogen source via the
peroxisomal enzyme D-amino
acid oxidase
Fungi (yeasts but not
Saccharomyces
cerevisiae)
Inability to grow on D-amino
acids
[165]
Methanol metabolism Many fungi can metabolise
methanol via peroxisomal
alcohol oxidase and
dihydroxyacetone synthase
Fungi (yeasts but not
Saccharomyces
cerevisiae)
Inability to grow on methanol [165]
Purine salvage pathway Trypanosomes cannot make
purines de novo. Glycosomes
contain a hypoxanthine-guanine
phosphoribosyl transferase and
xanthine phosphoribosyl
transferase which convert the
bases to the corresponding
purine mononucleotide
Trypanosomes [149]
Pyrimidine biosynthesis Orotate phosphoribosyl
transferase and orotidylate
decarboxylase in glycosomes
convert orotate to UMP
Trypanosomes [149]
Active oxygen
metabolism
Removal of active oxygen species
produced by peroxisomal
metabolism
Essentially all [166,167]
Metabolic processes that are at least partially compartmentalised within peroxisomes in diﬀerent organisms are listed. Many of these pathways are
shared with other cellular compartments, highlighting the need for extensive traﬃc of metabolites into and out of peroxisomes. For more detail the
reader is referred to the cited literature.
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and activation are intimately linked processes. A number of
ABC proteins and acyl CoA synthetases have been implicated
in lipid transport [23,25,27,31,32]; here, we review evidence for
the roles of peroxisomal ABC transporters in the metabolism
of lipids and formation of bioactive lipid metabolites.
4. Peroxisomal ABC transporters
ABC proteins are encoded by the largest gene superfamily in
all sequenced genomes to date and compromise a range of
mostly membrane-bound proteins with diverse functions.
Many of these proteins are involved in transport of a wide
variety of molecules (see reviews elsewhere in this volume).
ABC transporters are characterised by the sequence and orga-
nisation of an ATP binding domain. This domain, also known
as the nucleotide binding fold (NBF) contains two conserved
motifs: Walker A and Walker B, separated by ca. 90–120 ami-
no acids. A third, so-called ABC signature motif is situated up-
stream of the Walker B sequence [33]. A functional ABC
protein typically comprises two NBFs and two transmembrane
domains (TMDs), the latter of which contains several a-heli-
ces. In eukaryotic ABC transporters, these domains are gener-
ally organised as ‘‘full-size’’ transporters, with the topology
TMD–NBF–TMD–NBF (or the reverse: NBF–TMD–NBF–
TMD) or as two ‘‘half-size’’ transporters TMD–NBF (or
NBF–TMD).
In recent years, characterisation of prokaryotic and eukary-
otic genome sequences has allowed the complete identiﬁcation
of ABC genes in genomes representative of all major phyla.
[34–41]. The ABC family is divided into subgroups based on
phylogenetic relationships between their nucleotide binding do-
mains and members of each subfamily generally exhibit the
same domain structure [36]. Peroxisomal ABC transporters be-
long to subfamily D which is present in all eukaryotic taxa and
comprises from one to ﬁve members (Table 2). With the excep-
tion of plant representatives, all ABCD proteins are ‘‘half-size’’
transporters with the topology TMD–NBF [36]; Table 2. As is
the case for other half-size ABCs [42], ABCD proteins dimerise
to form functional transporters (Fig. 1). Table 2 lists ABCD
subfamily members from completed genomes.
4.1. Mammalian ABCD subfamily
The ABCD subfamily in humans comprises four members,
all of which are half-size ABC proteins: Adrenoleukodystro-
phy protein (ALDP; ABCD1), Adrenoleukodystrophy-related
protein (ALDRP; ABCD2) and the 69 and 70 kDa peroxi-
somal membrane proteins, PMP69 (ABCD4) and PMP70
(ABCD3) [43–48]. Members of the mouse ABCD subfamily
are strictly orthologous to those of humans [49] and conse-
quently, use of targeted gene deletions in mouse has proved
a useful tool for analysing the functions of mammalian perox-
isomal ABC transporters. Whilst ALDP has been extensively
studied, and, together with ALDRP and PMP70, has been
implicated in b-oxidation of fatty acids (see below), PMP69
has not been well characterised but is known to be ubiqui-
tously expressed [46,48]. The function of PMP69 has not yet
been determined, but based on sequence similarity, it has been
suggested to have a similar function to PMP70.
4.1.1. ABCD3: PMP70. The 70 kDa peroxisomal mem-
brane protein, PMP70, was the ﬁrst peroxisomal member of
the ABC superfamily to be identiﬁed. Discovered as a major
integral membrane protein of peroxisomes, it was originally
proposed to be a transporter, based on its membership of
the ABC superfamily and the cytosolic orientation of the
ATP binding domain [43]. Although PMP70 has been shown
to restore or partially restore peroxisomal biogenesis in mutant
cell lines defective in PEX2, an essential component of the per-
oxisome protein import machinery, the biochemical basis for
this is not clear [50,51]. Rather, a role for PMP70 in b-oxida-
tion appears likely: the induction of PMP70 not only parallels
peroxisome proliferation but also the induction of b-oxidation
enzymes ([52], and references therein). Strong evidence for a
transport function was provided by transfection studies with
Chinese hamster ovary (CHO) cell lines: overexpression of
rat PMP70 increased b-oxidation of palmitic acid (C16:0)
but not lignoceric acid (C24:0) and did not alter the number
or size of peroxisomes, arguing against a role in biogenesis
[52]. Latency experiments suggested that PMP70 mediates
transport of long-chain fatty acid (LCFA)-CoA across the per-
oxisomal membrane [52] and mutagenesis of conserved motifs
indicated a requirement for ATP binding and hydrolysis [52].
Interactions with 8-azido-[a-32P] ATP consistent with trans-
port function were subsequently demonstrated using both re-
combinant NBF fusion protein and intact, native PMP70
[53,54] and limited proteolysis revealed conformational
changes during the cycle of ATP binding and hydrolysis [55].
In addition to a role in peroxisomal import of straight chain
fatty acyl-CoA, PMP70 has recently been suggested to be in-
volved in the transport of 2-methylacyl-CoA esters, including
pristanoyl-CoA, and di- and trihydroxychoestanoyl-CoA
[56]. Pristanic acid and di- and trihydroxycholestanoic acids
are strictly oxidised in peroxisomes with pristanic acid under-
going three cycles of b-oxidation and di- and trihydroxycholes-
tanoic acid only a single b-oxidation cycle in peroxisomes to
produce chenodeoxycholic acid and cholic acid, respectively
[57].
4.1.2. ABCD1: ALDP. X-linked Adrenoleukodystrophy
(X-ALD) is the most common peroxisomal neurodegenerative
disease with a frequency of 1 in 21000 males in the USA [58]. It
exhibits a range of clinical phenotypes [59], characterised bio-
chemically by the accumulation of saturated, straight chain,
very long-chain fatty acids (VLCFA; C P 22:0) in plasma
and tissue. Since the primary cause of elevated VLCFAs is a
defect in b-oxidation, speciﬁcally, reduced activity of
VLCFA-acyl CoA synthetase (VLACS), it was originally
thought that VLACS was the candidate gene for X-ALD
[60–63]. However, positional cloning identiﬁed an ABC trans-
porter with similarity to a 70 Da peroxisomal protein as the X-
ALD gene [44] and mutations in the X-ALD gene have been
found in all X-ALD patients to date [64]. The gene product,
designated ALDP, was subsequently shown to be an integral
peroxisomal membrane protein with a cytosolic ATP binding
domain [65–68]. Expression of ALDP corrects b-oxidation of
VLCFA in X-ALD ﬁbroblasts, supporting the notion that
ALDP and not VLACS is responsible for X-ALD [69–71]. A
wide variety of mutations has been associated with X-ALD,
including intragenic deletions, point mutations, micro dele-
tions and insertion events [64,72,73]. Around 50% of muta-
tions described to date are missense mutations which
predominantly aﬀect speciﬁc, functionally important domains:
regions within the TMD which may be concerned with pro-
tein: protein interactions and peroxisomal targeting, a highly
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conserved ‘‘EAA’’ motif and the NBF [64]. Many mutations
result in protein instability or absence, such that up to 70%
of ALD patients lack immunoreactive ALD [67]. An up-to-
date survey of ALD mutations can be found at http:///
www.x-ald.nl. Confusingly, there is no clear cut association
with genotype and phenotype in X-ALD patients, for example,
no correlations can be made between nature of the mutation,
level of VLCFAs and severity of pathology [64,72]. The intra-
familial variability of ALD symptoms has so far deﬁed any at-
tempt at a simplistic biochemical explanation and has led to
the suggestion that modiﬁer genes may be responsible for var-
iable expression of the disease. The medical importance of X-
ALD and the ethical issues with human research prompted the
development of a mouse model. Targeted deletion of ALDP by
three groups replicated the biochemical defect of X-ALD, but
knockout mice did not exhibit severe neurological symptoms
until very late in development, further underlining the clinical
complexity of X-ALD [74–76].
4.1.3. Function of ALDP and relationship with
VLACS. Currently, the role(s) of ALDP in VLCFA metabo-
lism and the pathology of X-ALD are unclear and the
biochemical function of ALDP has yet to be determined
unequivocally. It has been variously suggested that ALDP is
directly involved in b-oxidation of VLCFA through transport
of VLCFAs, VLCFA-CoA, or the cofactors CoA, or ATP.
Substrate-induced conformational alterations suggest that
Table 2
ABCD proteins from genome-sequenced organisms
Organism Name Synonyms Accession No. Domain organisation References
Homo sapiens ABCD1 ALDP P33897 TMD–NBF [36,44]
ABCD2 ALDR, ALDL1, Q9UBJ2
ABCD3 PMP70, PXMP1 P28288
ABCD4 PMP69, P70R, PXMP1L O14678
Mus musculus ABCD1 ALDP P48410 TMD–NBF [49]
ABCD2 ALDR Q8BQ63
ABCD3 PMP70 Q91VT3
ABCD4 PMP69 O89016
Caenorhabditis elegans PMP1 C44B7.8 Q 18597 TMD–NBF [41,102]
PMP2 C44B7.9 Q18598
PMP3 C54G10.3 Q 18843
PMP4 T02D1.5 O45730
PMP5 T10H9.5 O76414
Drosophila melanogaster DmCG12703 Q9VWC8 TMD–NBF [36,39]
DmCG2316 Q8IMC0
Anopheles gambae Q7QFE4 TMD–NBF [39]
Q7PYR2
Arabidopsis thaliana CTS PXA1/PED3/AtPMP2 Q94FB9 TMD–NBF–TMD–NBF [111–113]
Oryza sativa OsCTSl Q84ZW6 TMD–NBF–TMD–NBF [40]
OsCTS2 Q5JJV5
Saccharomyces cerevisiae PXA1 PAT2/PALl/YPL147w P41909 TMD–NBF [34,106]
PXA2 PAT1/YKL188c P34230
Aspergillus fumigatus Q8TFX6 TMD–NBF
Q4WJU3
Candida albicans Q5A3L5 TMD–NBF
Q5AAI9
Candida glabrata Q6FJZ4 TMD–NBF
Q6FWG6
Neurospora crassa Q9P6C3 TMD–NBF
Q7SD69
Cryptococcus neoformis Q5KK89 TMD–NBF
Q55W02
Q5KNJ1
Q55Z76
Dictyostelium discoideum ABCD.1 Q8T8P5 TMD–NBF [38]
ABCD.2 Q8T8P3
ABCD.3 Q8T8P4
ABCD genes and proteins were identiﬁed from the literature surveys (indicated by references) and by BLAST searching non-redundant protein
databases using ALDP, CTS and PXA1,2 as input sequences.
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ALDP is directly involved in transport of L- and VLCFA-
CoAs across the peroxisomal membrane [77]. Alternatively,
roles in transport or stabilisation of the VLACS protein have
been proposed [44,64,65] and overexpression and knockout
studies of ALDP and VLACS have sought to test these
hypotheses. VLCFA accumulate in tissues of ALDP deﬁcient
X-ALD mice and ﬁbroblasts from these animals show reduced
rates of VLCFA b-oxidation, similar to ﬁndings for X-ALD
patients [74–76]. Immunoreactive VLACS was present in the
peroxisomal matrix of human and mouse X-ALD ﬁbroblasts,
indicating that X-ALD is required neither for transport nor
stabilisation of VLACS [78–80] but co-expression of ALDP
and VLACS had a synergistic eﬀect on both b-oxidation and
VLACS activity, suggesting a functional, rather than a physi-
cal interaction [79]. It has been assumed that reduced degrada-
tion evident in studies of ﬁbroblasts was responsible for
VLCFA accumulation in X-ALD tissues, however, it was dem-
onstrated recently that peroxisomal b-oxidation of VLCFA is
normal in tissues of X-ALD mice [81]. Furthermore, expres-
sion of VLACS in X-ALD cells improved b-oxidation [82],
contradicting an earlier report [79] and mice deﬁcient in perox-
isomal VLACS had reduced peroxisomal b-oxidation but nor-
mal VLCFA levels [83]. Thus peroxisomal b-oxidation and the
accumulation of VLCFA are uncoupled in the mouse model:
ALDP is not necessary to maintain VLACS activity and the
control of VLCFA levels does not depend on the direct inter-
action of VLACS and ALDP.
This apparent paradox has led to the hypothesis that an
indirect mechanism involving mitochondrial dysfunction
might be responsible for the accumulation of VLCFA in X-
ALD [81]. A close relationship between mitochondrial and
peroxisomal b-oxidation was established and inhibition of
mitochondrial b-oxidation was accompanied by a signiﬁcant
reduction of peroxisomal VLCFA b-oxidation. It was pro-
posed that ALDP deﬁciency inﬂuences mitochondrial function
causing an increase in LCFA. Since peroxisomal VLACS has a
higher aﬃnity for LCFA than for VLCFA, the net conse-
quence would be saturation of peroxisomal VLACS, resulting
in VLCFA accumulation. It was further suggested that accu-
mulation of VLCFA could cause mitochondrial damage [81].
However, a detailed study of mitochondrial ultrastructure
and function in X-ALD tissues indicated that this was not
the case and also that mitochondrial dysfunction did not
underpin accumulation of VLCFA [84]. This raises the ques-
tion: what is the cause of elevated VLCFA in X-ALD cells,
if not impaired degradation? The answer may lie in VLCFA
synthesis: X-ALD cells exhibit increased fatty acid elongation,
which could contribute to increased levels of VLCF As in X-
ALD [85]. However, it is not known how mutations in ALDP
relate to microsomal fatty acid elongation.
4.1.4. ABCD2: ALDRP. ALDRP is highly similar to
ALDP (88% similarity and 67% identity at the amino acid le-
vel) [45,47] and both gene structure and phylogenetic analysis
suggest relatively recent divergence from a common ancestor
[86]. The expression patterns of ALDP and ALDRP are dis-
tinct but overlapping with predominant expression of ALDRP
in brain and heart [45,47,87–89]. This, together with close se-
quence homology, has led to the suggestion that ALDRP
and ALDP are functionally redundant, performing a similar
role in diﬀerent cell types. Strong evidence in support of this
hypothesis has recently been obtained ([88,89] and see below).
4.1.5. Rescue of X-ALD: functional implications and role of
ALDRP. X-ALD ﬁbroblasts have approximately 30% of wild
type VLCFA b-oxidation activity, therefore absence of ALDP
results in the reduction but not elimination of VLCFA b-oxi-
dation, suggesting either that there are compensatory or
redundant activities or that the eﬀect of ALDP on VLCFA
b-oxidation is indirect. X-ALD ﬁbroblasts also have normal
levels of LCFA (C16:0) oxidation, which is consistent with
the endogenous expression of PMP70 in this cell type
[61,62,74]. Expression not only of ALDP and ALDRP but also
of PMP70 restores VLCFA b-oxidation in X-ALD ﬁbroblasts
Fig. 1. Domain organisation of the ABCD subfamily. (A) Cartoon of a generalised ‘‘half-size’’ ABC transporter. In ABC subfamily D, the TMD
precedes the cytosolically oriented NBF. The number of a-helices in the TMD of ABCD proteins has not been established experimentally and may
vary between diﬀerent proteins. (B–D) ABCD proteins in peroxisomes of yeast, plants and mammals. Yeast has two half-size ABCD proteins, Pxa1p
and Pxa2p, which form a heterodimer in vivo and in vitro (B), whereas plants have a single, full-size peroxisomal ABC protein, CTS, which is
essentially a fused heterodimer (C). Mammals contain four diﬀerent half-size proteins: ALDP, ALDRP and the 69 and 70 kDa peroxisomal proteins,
PMP69 and PMP70. Although these proteins can heterodimerise in vitro, it is still not unequivocally established whether this happens routinely
in vivo (D).
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[70,90–92] indicating a degree of functional overlap. The latter
observation is surprising given that PMP70 is implicated in
transport of LCFA-CoA and overexpression in CHO cells
did not increase VLCFA b-oxidation [52] and perhaps indi-
cates a non-speciﬁc eﬀect. Peroxisomal VLCFA b-oxidation
could also be restored by treatment of X-ALD cells or animals
with the peroxisome proliferator, fenoﬁbrate [92] and with
pharmacological agents such as sodium 4-phenylbutryate
(4PBA) [90]. Initially, correction of VLCFA b-oxidation and
VLCFA levels was attributed to increases in ALDRP expres-
sion and pharmacological induction of functionally redundant
transporters was proposed as a promising therapeutic ap-
proach for X-ALD [88,90,92]. Although some reports suggest
that enhancement of VLCFA b-oxidation by 4PBA and other
pharmacological agents is associated with induction of mito-
chondrial LCFA b-oxidation, rather than with induction of
ALDRP [81,93], the neurological and biochemical phenotypes
of X-ALD mice can be ameliorated by overexpression of
ALDRP [88]. Moreover, double ALD,ALDR mutants
exhibited a more severe phenotype than ALD-single mutants.
This provides unequivocal evidence that ALDP and ALDRP
share at least some functionality but also suggests that
ALDRP has additional roles in vivo. More detailed analysis
revealed that ALDRP expression in neuronal tissue is highly
cell-type speciﬁc: although deletion of ALDRP did not lead
to higher levels of VLCFA in neural tissue in general [88],
VLCFA were indeed elevated in dorsal root ganglia, a cell
population in which ALDRP expression is high [89]. Levels
of other peroxisomal metabolites were normal. Interestingly,
the electrophysiological and neurological phenotypes of
ALDP- and ALDRP-mutant mice were distinct, perhaps
reﬂecting the roles of ALDP and ALDRP in diﬀerent cell
types. It could not be concluded whether elevated VLCFA
was a direct or indirect eﬀect of deletion of either gene. Whilst
the precise biochemical function(s) of ALDP and ALDRP re-
main unclear, the genetic evidence from analysis of X-ALD pa-
tients and knockout mice nevertheless points to important
roles in normal physiology.
4.1.6. Interactions and function: hetero and homodimerisa-
tion. Since humans have four peroxisomal ABC transporters
[43–46], it has been suggested that these peroxisomal half-
transporters dimerise in the peroxisomal membrane to form
functional ‘‘full-size’’ transporters and that heterodimerisation
might contribute to functional diversity [94]. Homodimerisa-
tion of ALDP and heterodimerisation of ALDP with ALDR
and PMP70 have been demonstrated in vitro using yeast
two-hybrid assays and co-immunoprecipitation of recombi-
nant proteins [64,95]. Native complexes of ALDP and
PMP70 have also been isolated by coimmunoprecipitation
and a tentative link between transporter phosphorylation
and complex formation established [54]. Despite the biochem-
ical evidence for heterodimerisation, X-ALD is associated only
with mutations in ALDP and not with any of the remaining
three peroxisomal ABC transporters. If dimerisation of ALDP
were required for function, then X-ALD mutations in a hete-
rodimerisation partner would be expected on statistical
grounds. Moreover, the distinct expression patterns of ALDP,
ALDR and PMP70 in mice and humans suggest that they
function independently as homodimers [87,89,96–98]. Whilst
it is clear that heterodimers can be formed in vitro, the stoichi-
ometry of ABC transporter expression must be an important
factor in determining interactions between the diﬀerent half-
transporters and recent protein puriﬁcation studies employing
stringent detergent solubilisation conditions suggest that
homomeric interactions of ALDP and PMP70 prevail in vivo
[99]. Altering the expression of one or more protein could im-
pact on peroxisomal function in two ways: by competing for
membrane insertion sites with endogenous transporters or by
forming heterodimers with altered or compromised function.
Interestingly, overexpression of PMP70 in CHO cells promotes
b-oxidation of LCFA suggesting that it acts as a homodimer
in vivo. However, b-oxidation of VLCFA was depressed by
30–40% in the same cells, suggesting displacement of ALDP
or heterodimerisation with PMP70 [52]. Similarly, co-expres-
sion of normal and mutated ALDP reduced protein function,
suggesting either that peroxisomes contain a limited number of
sites for integration of ALDP or that ALDP homodimers were
titrated out by the formation of non-functional mutant/wild
type heterodimers [100].
In addition to forming homo- and heterodimers, peroxi-
somal ABC transporters are expected to be intimately associ-
ated with other peroxisomal membrane proteins, for
example, yeast two-hybrid and GST pull-down assays have
shown that PEX19 interacts with ALDP, ALDRP and
PMP70, and is likely to be involved in traﬃcking these proteins
to the peroxisomal membrane [101].
4.2. Nematode ABCD subfamily
The model nematode, Caenorhabditis elegans, contains ﬁve
putative ABCD transporters, two of which are closely linked
and may be subject to common regulation [41,102] (Table 2).
RNAi silencing of genes encoding peroxisomal proteins dem-
onstrated that, although enzymes of b-oxidation are not re-
quired for post-embryonic development in C. elegans, a
defect in CePMP1, 2 and 4 results in arrest at the ﬁrst stage
in larval development, indicating the importance of peroxi-
somal ABC transporters in worm physiology [102].
4.3. Yeast ABCD subfamily
Despite extensive studies of peroxisomal ABC proteins in
mammalian systems, the functions of ABCD transporters are
perhaps best understood in baker’s yeast, Saccharomyces cere-
visiae. Yeast represents a simple yet powerful experimental sys-
tem with speciﬁc advantages for analysing b-oxidation: ﬁrstly,
this pathway is restricted exclusively to peroxisomes, secondly,
yeast is able to use fatty acids as the sole carbon source and
this property, together with the ready availability of disruption
mutants permits rapid analysis of gene function. This
prompted a search for yeast homologues of ALDP and
PMP70 which were initially isolated during the genome
sequencing project [103] and in PCR screens for ABC trans-
porter sequences using RNA from oleic acid-induced yeast
[104,105]. Yeast contains two ALDP homologues: PXA1
(peroxisomal ABC-transporter 1), also known as PAT2 or
PAL1, and PXA2, also known as PAT1 [104–106]. Cellular
fractionation and immunogold microscopy demonstrated that
Pxa1p and Pxa2p are both integral peroxisomal membrane
proteins [104–106].
The Dpxa1 and Dpxa2 deletion mutants are unable to
grow on oleate (C18:1) as the sole carbon source and exhibit
reduced b-oxidation of this LCFA. However, PXA1 and 2
are not required for peroxisome biogenesis or for growth
on medium chain fatty acids such as laureate (C12:0) or
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myristate (C14:0) [104–106], indicating a speciﬁc function for
these transport proteins in b-oxidation of LCFA. Since the
phenotypes of both single mutants and the double mutant
are identical, it has been proposed that Pxa1p and Pxa2p
operate as a heterodimer to form a functional transporter
[106], and this has been demonstrated experimentally by
co-immunoprecipitation [107]. Studies using permeabilised
yeast spheroplasts established that Pxa2p was required for
the peroxisomal transport of the C18:1-CoA, a long-chain
acyl CoA ester, but not for import of C8:0-CoA [108], sug-
gesting a model in which LCFA are activated in the cyto-
plasm and are imported into the peroxisome by the Pxa1p/
Pxa2p heterodimer (Fig. 2; [106,108]). In contrast, medium
chain free fatty acids (MCFAs) enter yeast peroxisomes as
free acids, and are activated by peroxisomal acyl CoA syn-
thetase, Faa2p [106]. The peroxisomal membrane protein,
Pex11p, has been shown to be required for MCFA b-oxida-
tion [109]. Although Pex11p is not an ABC transporter, it is
co-regulated with the b-oxidation machinery and latency
studies suggest that Pex11p could provide the MCFA-CoA
synthetase (Faa2p) with substrate [109]. However, the latter
hypothesis has been challenged by analysis of PEX11 knock-
out mice [110].
4.4. Plant ABCD subfamily
An inventory of Arabidopsis ABC proteins assigned two
genes to the ABCD subfamily, designating them as AtPMP1
(A1g54350) and AtPMP2 (At4g39850) (Arabidopsis thaliana
peroxisomal membrane protein; [37]). Although the protein
encoded by AtPMP1 is a half-size transporter with 31% amino
acid identity to ALDP, orthology analysis does not group it
with ALDP and examination of the peptide sequence reveals
a putative chloroplast transit peptide (http://www.tigr.org/tigr-
scripts/tgi/). The second gene, AtPMP2, has been identiﬁed in
three independent forward genetic screens and is also known
as CTS (COMATOSE), AtPXA1 (Arabidopsis thaliana perox-
isomal ABC transporter 1) or PED3 (peroxisomal defective 3),
referred to hereafter as CTS [111–113]. Unlike the yeast and
mammalian peroxisomal ABCs, CTS encodes a full-size,
1337 aa ABC protein with predicted molecular mass of ca.
150 kDa. This was conﬁrmed experimentally by immunoblot-
ting, and CTS was also shown to be an integral peroxisomal
membrane protein [111,112]. The N- and C-terminal halves
of the protein are each around 35% identical to ALDP, sug-
gesting that open reading frames encoding two half-size trans-
porters have become fused during the course of evolution
to specify a single protein product with the topology
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Fig. 2. Peroxisomal fatty acid import in yeast and plants. In yeast, LCFAs are activated in the cytoplasm by ACS. LCFA-CoA esters are imported
into the peroxisome by the Pxa1p/Pxa2p heterodimer. In contrast, MCFAs are imported independently of Pxa1p/Pxa2p and activated in the
peroxisome by the action of the acyl CoA synthetase Faa2p. Faa2p requires a peroxisomal pool of ATP and CoA which are supplied by the
peroxisomal ANT and an as-yet characterised CoA transporter (?) respectively. The peroxin, Pex11p, has been suggested to play a role in the import
of MCFA, although it is not thought to be a transport protein per se. In plants, the transport substrate has not been identiﬁed experimentally, but it
is plausible that free FAs are imported by the action of CTS and esteriﬁed to CoA by one of the peroxisomal acyl CoA synthetases (LACS6 and
LACS7). However, it cannot be excluded that acyl CoAs are imported, as is the case for yeast. The import of cofactors ATP and CoA is likely to be
similar to that in yeast.
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TMD–NBF–TMD–NBF. This gene structure appears to be
conserved in plants, since examination of the rice genome
sequence reveals the presence of two sequences encoding full-
size proteins with high identity to ALDP (Table 2; [40]).
Two genes also appear to be represented in barley and other
grass EST databases, suggesting either that gene duplication
has occurred after the monocot/dicot divide, before the evolu-
tion of the grasses, or that duplication occurred prior to the
divergence of monocots and dicots and the second copy has
been lost from the Arabidopsis genome (not shown). Thus,
plants can be considered to contain one or more ‘‘fused hetero-
dimers’’.
The isolation and characterisation of mutant alleles have
provided considerable insight into the functions of peroxi-
somal ABC transporters in plants. The ped3 allelic series and
the pxa1-1 mutant were isolated in screens for resistance to
the auxin precursors 2,4-dichlorophenoxybutyrate (2,4-DB)
and indole butyric acid (IBA), [112–115]. By analogy with b-
oxidation of fatty acids, 2,4-DB and IBA are thought to be
activated by CoA esteriﬁcation and undergo one cycle of b-
oxidation to shorten the acyl chain by two units, yielding
2,4-dichlorophenoxyacetate (2,4-D) and indole acetic acid
(IAA), respectively. The conversion to these bioactive auxins
causes stunting of roots in wild type plants (Fig. 3). Although
exogenous application of 2,4-D and IAA also inhibits root
growth in ped3 and pxa1-1, the mutants are unable to convert
2,4-DB and IBA and therefore can elongate their roots in the
presence of these precursor compounds. This implies that the
lesion in these mutants is a block in b-oxidation, not only of
auxin precursors, but also of fatty acids. In oilseeds such as
Arabidopsis, b-oxidation plays an important role in mobilisa-
tion of seed storage lipids, which, together with glyoxylate cy-
cle, is essential for the provision of energy and carbon
skeletons for seedling establishment. In agreement with this
role, ped3 and pxa1-1 mutants are unable to establish in the
absence of exogenous sucrose. This phenotype is shared with
other Arabidopsis b-oxidation mutants [25]. It should be noted
that not all seeds store lipid as the major energy source for
establishment. Nevertheless, the aleurone layer of starchy
seeds such as those of wheat and barley contains oil which
plays an important role in starch mobilisation by providing en-
ergy for the synthesis of copious quantities of a-amylase [116].
Thus a role for CTS orthologues can be envisaged in germina-
tion and establishment of cereals as well as in oilseeds.
In apparent contrast to ped3 and pxa1-1, cts-1 was isolated
as a mutant severely compromised in germination [111,117].
Analysis of the cts-1 locus reveals a chromosomal transloca-
tion at a position in the open reading frame corresponding
to amino acid 616. A second allele, cts-2, isolated by reverse
genetics, contains a T-DNA insertion at aa 117, and has a very
similar phenotype to cts-1 [111]. Absence of transcripts and
protein from cts-1 and cts-2 suggests that they are essentially
null alleles ([111]; Baker et al., unpublished data), but the block
in germination can be overcome to varying degrees by classical
dormancy-breaking treatments such as mechanical rupture of
the seed coat and chilling of imbibed seeds prior to assay for
germination. In common with ped3 and pxa1-1, cts-1 and
cts-2 are unable to establish in the absence of sucrose, how-
ever, rescued cts plants become photosynthetic following
establishment and can complete a full life cycle [111]. Although
exogenous sucrose permits establishment, it does not rescue
the germination defect of cts, implying that CTS has a distinct
function in the transition from dormancy to germination.
Since the ped3 and pxa1-1mutants do not appear to be aﬀected
in germination [112,113], it was proposed that these represent
weaker alleles, in apparent agreement with the position of the
respective mutations in the CTS protein [111]. However, com-
parative germination studies under controlled conditions sug-
gest that the germination phenotype of pxa1 at least, is
almost as severe as that of cts-1 and cts-2 (S. Footitt, G. For-
bes, J. Marquez, H. Schmuths, E. Carrera, A. Baker, F. The-
odoulou and M. Holdsworth, manuscript in preparation).
An interesting task for future research will be to elucidate
the biochemical role of CTS in the transition from dormancy
to germination.
Electron microscopic examination of cotyledons from cts-1
seedlings revealed a marked inability to break down lipid
bodies. Accordingly, proﬁling of fatty acids and acyl-CoA es-
ters demonstrated that around 70% of storage lipid-derived
fatty acids were retained in cts-1 and cts-2. Most notably, lev-
els of fatty acyl CoAs were higher in the mutants, in particu-
lar the C20:1, C20:0 and C22:1 VLC-CoAs which are markers
for Arabidopsis storage lipid [111]. This phenotype is com-
mon to other b-oxidation and associated single and double
mutants, including peroxisomal long-chain acyl CoA synthe-
tase (lacs6 lacs7), acyl CoA oxidase (acx1 acx2), thiolase
(kat2) and peroxisomal citrate synthase (csy2 csy3) (reviewed
in [25]). Accumulation of CoAs had no eﬀect on peroxisome
morphology in cts and lacs6 lacs7, but caused enlargement
and distortion of peroxisomes in downstream mutants. This
is interpreted as reﬂecting the intracellular location of CoAs:
in downstream mutants, CoAs must accumulate in the perox-
isome, whereas in cts and lacs6 lacs7, they are presumed to be
extra-peroxisomal, suggesting the existence of an as-yet
uncharacterised cytosolic or microsomal acyl CoA synthetase
[25,118].
The retention of FA and acyl-CoAs in cts mutants and the
fact that CTS encodes an integral membrane protein suggest
that CTS mediates transport of FA, FA-CoA or possibly
cofactors for b-oxidation into the peroxisome. Although other
scenarios are possible, (for example, CTS might regulate the
activity of another transporter or of enzymes involved in lipid
catabolism) this remains the simplest hypothesis. If this is the
case, what are the substrates for CTS? CTS is unlikely to be
an ATP transporter, since a peroxisomal adenine nucleotide
translocator (ANT) belonging to the mitochondrial carrier
protein family has been identiﬁed in yeast and Arabidopsis
[21,119]. Similarly, in mammals and yeast, CoA is imported
into mitochondria by a carrier protein, rather than by an ATP-
ase, and it is plausible that a similar transporter is present in
peroxisomes [120], although some authors suggest that a spe-
ciﬁc CoA transporter is not required by this organelle [18].
Thus, it is most likely that CTS transports substrates for b-oxi-
dation, although it should be noted that this hypothesis awaits
unequivocal experimental support. The retention of acyl CoA
in cts-1 and cts-2 could be interpreted as evidence that the sub-
strate for CTS is acyl-CoA, as is the case for the yeast hetero-
dimeric transporter, Pxa1p/Pxa2p [108]. However, retention of
CoA is also consistent with FA as substrate for CTS: since
C20:1 is not a component of structural lipids, it may accumu-
late as the CoA ester because it lacks an alternate sink. The
Arabidopsis peroxisomal acyl CoA synthetases, LACS6 and
7, exhibit preference for very long-chain substrates and their
active sites are located on the matrix side of the membrane
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[121,122]: therefore CTS may import free FA which are acti-
vated in the peroxisome (Fig. 2).
The ﬁnding that all fatty acid chain lengths are mobilised in
the WT and retained to some extent in cts mutants argues for a
wide substrate speciﬁcity or alternatively for a regulatory role
for CTS [111]. Moreover, the resistance of cts/ped3/pxa1 mu-
tants to 2,4-DB and IBA suggests that CTS can mediate the
uptake of these compounds (or their CoA esters). The concept
of CTS as a broad speciﬁcity transporter or transport regulator
and the requirement for b-oxidation in biosynthesis of the li-
pid-derived plant hormone, jasmonic acid (JA) led to the dis-
covery that CTS is involved in JA accumulation in
Arabidopsis leaves [123]. Both basal and wound-induced JA
were markedly reduced in cts plants and JA-induced gene
expression was compromised. In JA biosynthesis, a cyclopen-
tenone intermediate, 9S,13S-12-oxophytodienoic acid
(OPDA), itself a potent signalling molecule, is synthesised in
the chloroplast and transported to the peroxisome where it is
reduced and undergoes three cycles of b-oxidation to yield
JA (Fig. 3). A model was proposed in which OPDA (or an-
other JA intermediate) is transported into the peroxisome by
two parallel pathways: a CTS-dependent route and a passive
route involving anion trapping in the alkaline peroxisomal ma-
trix [123]. A potential role for CTS in hormone metabolism
points to functions beyond germination and establishment
and accordingly, CTS is expressed throughout the plant.
A model in which CTS acts as a transporter for a wide
range of substrates is reminiscent of multidrug resistance
ABC transporters which transport structurally disparate com-
pounds which share only broadly generic chemical properties
(e.g., cationic basic compounds; organic anions, etc.). It may
be that further potential CTS substrates can be predicted,
based on their physicochemical properties. Whilst such a
model represents a simple scenario consistent with current
experimental data, it is also possible that CTS functions
not as an ATP-dependent primary pump but as a transport
regulator or possibly in both modes. There are precedents
for this amongst ABC transporters of other subclasses, for
example: mammalian multidrug resistance P-glycoproteins
are both ATP-dependent drug pumps and regulators of vol-
ume-activated chloride channels [124]. Similarly, Arabidopsis
multidrug resistance associated proteins 4 and 5 not only ex-
hibit pump activity but also regulate stomatal aperture
through as-yet unknown mechanisms which probably involve
modulation of ion transport activity ([125–127] and see
reviews elsewhere in this volume). It will be interesting to
Fig. 3. b-Oxidation of fatty acids and signalling compounds in plants. (A) ‘‘Core’’ b-oxidation of straight chain fatty acids. Substrates are activated
by esteriﬁcation to CoA prior to b-oxidation. Acyl CoA is then converted to a 2-trans-enoyl CoA by acyl CoA oxidase and the multifunctional
protein catalyses the hydration of 2-trans-enoyl-CoA to 3-hydroxyacyl-CoA and subsequent oxidation to 3-ketoacyl-CoA. In the ﬁnal reaction of b-
oxidation, 3-ketoacyl-CoA thiolase catalyses the thiolytic cleavage of 3-ketoacyl CoA to yield acyl CoA and acetyl CoA. This cycle is repeated with
the removal of two-carbon units until the fatty acid is completely oxidised. (B) The jasmonate precursor, OPDA, which is derived from the 18-carbon
straight chain fatty acid, linolenic acid (18:3), is converted to JA by three rounds of b-oxidation. Similarly, a single cycle of b-oxidation is required for
conversion of the auxin precursors 2,4-DB and IBA to 2,4-D and IAA, respectively. Following b-oxidation steps, action of a thioesterase is also
required to release the free acids (2,4-D, IAA and JA) from their CoA esters. (C) Whilst wild type plants of both Landsberg erecta (Ler) and
Wassilewskija (Ws) ecotypes are sensitive to both 2,4-D and 2,4-DB, cts mutants are resistant to 2,4-DB which cannot be oxidised to 2,4-D in these
plants. The photograph in panel C is reproduced with permission from reference [111].
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determine whether these concepts also apply to CTS or other
ABCD proteins.
4.5. Prokaryotic homologues?
Both Sinorhizobium meliloti, a legume symbiont, and Bru-
cella abortus, a mammalian pathogen, require the BacA pro-
tein to establish intracellular infections in their hosts [128].
BacA does not contain an NBF but shares sequence similarity
with the TMD region of the peroxisomal ABC transporters
and was found to play a role in the VLCFA content of lipid
A in both organisms, suggesting that it is involved in transport
of fatty acids, although it is also possible that BacA interacts
with homologues of MsbA, a lipid ﬂippase which is responsible
for movement of lipopolysaccharide to the periplasmic face of
the inner membrane. Whether this has functional implications
for eukaryotic ABC transporters is not clear, since the NBF,
critical for activity in peroxisomal ABC transporters, is not
conserved in BacA. The evolutionary origin of BacA is also
an interesting but unresolved question.
5. Conclusions and perspectives
Whilst peroxisomal ABC transporters are present in all
eukaryotic genomes, there are important diﬀerences in the
organisation and functions of the ABCD subfamily in diﬀerent
taxa. It has been noted that orthologous pairs of ABC genes
are found much less frequently than in other conserved gene
families, and this appears to be the case for peroxisomal
ABC proteins [41]. We have attempted to assess the evolution-
ary relationships of the ABCD subfamily but found that trees
of diﬀering topology were supported by similar statistical
probabilities, preventing meaningful inferences. However, it
is likely that an ancestral half-size protein gave rise to the cur-
rent spectrum of transporters. An ancestral function is harder
to propose: although it is tempting to speculate that peroxi-
somal import of fatty acids or fatty acyl CoAs could be the
function of a prototypical ABCD transporter, phylogenetic
analysis of organellar distribution has led to the suggestion
that the yeast proteins, Pxa1p and Pxa2p, are originally of
mitochondrial origin [129]. The signiﬁcance of this is unclear:
although this might reﬂect transfer of functions from mito-
chondria to peroxisomes, this hypothesis is not proven and
fatty acids are imported into mammalian mitochondria by a
diﬀerent mechanism involving the concerted action of carnitine
palmitoyl transferase I, the carnitine/acylcarnitine translocase
and carnitine palmitoyl transferase II [57].
Regardless of the phylogenetic details, the varying functions
of peroxisomes suggest that the requirements for transport of
substrates across the peroxisomal membrane diﬀer between
organisms and that the functions of ABCD proteins are likely
to have evolved in concert with the roles of peroxisomes in dif-
ferent organisms (Table 1). Whether b-oxidation is conﬁned to
peroxisomes, as in yeast and plants, or is also shared with the
mitochondrion, as in animals, may be an important factor. In
some organisms, the diﬀerential expansion of the ABCD fam-
ily reﬂects not only functional diversiﬁcation but also both tis-
sue speciﬁcity, as is the case for the four mammalian
peroxisomal ABC transporters. In contrast, although plants
are noted for their peroxisomal diversity [130] and contain
more ABC proteins in total than other organisms of similar
complexity [37], Arabidopsis has only a single peroxisomal
ABC protein which is expressed throughout the plant, presum-
ably in diﬀerent peroxisome subtypes [112,123]. Analysis of
knockout mutants has indicated roles in fatty acid catabolism,
hormone synthesis and development – this raises the question
of how several apparently diﬀerent roles for this protein are
controlled and co-ordinated. One potential answer is that this
could be achieved by peroxisomal specialisation, i.e., the pre-
dominant function of CTS could be dictated by the comple-
ment and substrate-speciﬁcity of downstream enzymes in
each peroxisome sub-type or possibly by interaction with dif-
ferent membrane proteins.
Although many biochemical details are yet to be determined,
models for peroxisomal import of FA appear to diﬀer between
organisms (Fig. 2) and the question remains of whether perox-
isomal ABC transporters all act as ATP-dependent pumps of
lipids and lipid metabolites, or whether they mediate or regu-
late transport through other mechanisms. The evidence for di-
rect transport is strong in the case of Pxa1p/Pxa2p and PMP70
but less so for ALDP and other ABCD proteins. Unequivocal
demonstration of transport will require the reconstitution of
peroxisomal ABC proteins into lipid vesicles, a challenging
task given the diﬃculties of purifying membrane proteins,
the limited water solubility of putative substrates and the hete-
rodimeric nature of at least some transporters. A further com-
plicating factor is the potential requirement for accessory
proteins which may deliver lipophilic substrates to the peroxi-
some or interact with the transporter on the lumenal side of the
membrane. Nevertheless such studies are key to our under-
standing of the ABCD subfamily and, together with genetic
approaches, may also lead to the identiﬁcation of novel sub-
strates and functions which can only add to the interest of this
fascinating group of proteins.
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